Dr. Ayala is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 5th St S
Saint Petersburg, FL 33701Phone+1 727-767-4176Fax+1 727-767-4379
Education & Training
Emory University School of MedicineFellowship, Pediatric Hematology/Oncology, 1990 - 1993
San Juan City HospitalResidency, Pediatrics, 1986 - 1990
University of Puerto Rico School of MedicineClass of 1986
Certifications & Licensure
FL State Medical License 1993 - 2027
GA State Medical License 1990 - 1993
American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Study of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) Tumors Start of enrollment: 2008 Sep 01
- Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL) Start of enrollment: 2011 Jul 18
- Metformin in Children With Relapsed or Refractory Solid Tumors Start of enrollment: 2012 Sep 24
Publications & Presentations
PubMed
- Hemophilia prophylaxis: defining outcome measures by regulatory agencies and ISTH.Nathan Visweshwar, Irmel Ayala, Michael Jaglal, Bradley Fletcher
Journal of Thrombosis and Haemostasis. 2024-10-01 - Impact of Phlebotomy on Quality of Life in Low-Risk Polycythemia Vera.Nathan Visweshwar, Bradley Fletcher, Michael Jaglal, Damian A Laber, Ankita Patel
Journal of Clinical Medicine. 2024-08-22 - Correction to: Clinical and Treatment History of Patients with Partial DiGeorge Syndrome and Autoimmune Cytopenia at Multiple Centers.Priya K Patel, Michell Lozano Chinga, Melis Yilmaz, Sonia Joychan, Boglarka Ujhazi
Journal of Clinical Immunology. 2024-02-29
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
